Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data.
Authors
Sánchez-Rodríguez C, Gago-Veiga AB, García-Azorín D, Guerrero-Peral ÁL, Gonzalez-Martinez A
Abstract
Real-world data (RWD) has identified potential predictors of response to anti-CGRP therapies in patients with chronic migraine (CM). This review aims to synthesize the most remarkable findings published to date regarding this topic.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
